Brazil Anvisa Authorizes Import of Test Drug for Creutzfeldt-Jakob Patient

Brazil's health regulator Anvisa authorized the import of an experimental medicine for influencer Lito Sousa, who has Creutzfeldt-Jakob disease, a fatal and incurable condition. The authorization is a regulatory step for compassionate use, not evidence of efficacy. This highlights the growing role of social media in accelerating access to unproven treatments.